A Two-Stage Phase 2 Study Of A-007 Topical Gel in High-Grade Squamous Intraepithelial Lesions (HSIL)
Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
A-007 is an investigational therapy which may be effective in the treatment of pre-cancerous
cervical dysplasia (abnormal cell growth). The purpose of this study is to evaluate the
safety and efficacy of A-007, when used to treat high-grade cervical dysplasia.